References
- WHO. World malaria report. Geneva, Switzerland: World Health Organization fact sheet; 2013: Available from: https://www.who.int/malaria/publications/world_malaria_report_2013/en/. Accessed 620, 2020.
- O’Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10(8):545–555. doi:10.1016/S1473-3099(10)70096-720637696
- Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(10):982–991. doi:10.1016/S1473-3099(14)70855-225213732
- Baird JK. Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev. 2009;22:508–534. doi:10.1128/CMR.00008-0919597012
- Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. New Eng J Med. 2009;361(5):455–467. doi:10.1056/NEJMoa080885919641202
- Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in Western Cambodia. New Eng J Med. 2008;359(24):2619–2620. doi:10.1056/NEJMc080501119064625
- Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77(6_Suppl):79–87. doi:10.4269/ajtmh.2007.77.7918165478
- Rodriguez-Morales AJ, Benitez JA, Arria M. Malaria mortality in venezuela: focus on deaths due to Plasmodium vivax in children. J Trop Pediatr. 2007;54(2):94–101. doi:10.1093/tropej/fmm07417906318
- Tjitra E, Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5(6):e128. doi:10.1371/journal.pmed.005012818563962
- Deress T, Girma M. Plasmodium falciparum and Plasmodium vivax Prevalence in Ethiopia: A systematic Review and Meta Analysis. Malar J Treat. 2019;2019. doi:10.1155/2019/7065064.
- Mendis K, Sina BJ, Marchesini PCR, Sina BJ. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64(1_suppl):97–106. doi:10.4269/ajtmh.2001.64.9711425182
- Mueller I, Galinski MR, Baird JK, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009;9(9):555–566. doi:10.1016/S1473-3099(09)70177-X19695492
- WHO. Guidelines for the treatment of malaria. Geneva; 2015. Available from: https://www.who.int/docs/default-source/documents/publications/gmp/guidelines-for-the-treatment-of-malaria-eng. Accessed 520, 2019.
- Teka H, Petros B, Lawrence Y, et al. Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. Malar J. 2008;7(1):220. doi:10.1186/1475-2875-7-22018959774
- Ketema T, Bacha K, Birhanu T, Petros B. Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, South-West Ethiopia. Malar J. 2009;8(1):177. doi:10.1186/1475-2875-8-17719642976
- Zema Z, Sulaiman S, Woldie M, Yesuf EA. Therapeutic efficacy of chloroquine in Plasmodium vivax at health centers in Jimma Town, South-West Ethiopia. J Health Med Nurs. 2016;23:13–19.
- Assefa M, Eshetu T, Biruksew A. Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Hossana Health Care Centre, southern Ethiopia. Malar J. 2015;14(1):458. doi:10.1186/s12936-015-0983-x26577669
- WHO. Methods for surveillance of antimalarial drug efficacy. Geneva, Switzerland; 2009. Available from: https://www.who.int/malaria/publications/atoz/9789241597531/en/. Accessed 910, 2019.
- FMOH. National malaria guidelines. Fourth edition, Addis Ababa; 2017. Available from: https://www.humanitarianresponse.info/sites/www.humanitarianresponse.info/files/documents/files/eth_national_malaria_guidline_4th_edition.pdf. Accessed 1210, 2020.
- WHO. Monitoring anti-malarial drug resistance Report of a WHO Consultation Geneva, Switzerland; 2002. Available from: https://apps.who.int/iris/handle/10665/67590. Accessed 623, 2018.
- Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 8th ed. New York: John Wiley & Sons Inc; 2005.
- Shrestha MB, Dunn L. The declaration of Helsinki on medical research involving human subjects: a review of seventh revision (Medical Education). J Nepal Health Res Counc. 2020;17(4):548–552. doi:10.33314/jnhrc.v17i4.104232001865
- Baird JK. Chloroquine resistance in Plasmodium vivax. Antimicr Agents Chemother. 2004;48(11):4075–4083. doi:10.1128/AAC.48.11.4075-4083.2004
- Getachew S, Thriemer K, Auburn S, et al. Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia. Malar J. 2015;14(1):525–533. doi:10.1186/s12936-015-1041-426702611